SCIENTURE HOLDINGS, INC. Derivative Liability, Current
SCIENTURE HOLDINGS, INC. (SCNX) had Derivative Liability, Current of $1.96 million as of 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-08-18
- 2023-06-30: Derivative Liability, Current $1.96M.
- 2023-03-31: Derivative Liability, Current $508.64K.
- 2022-12-31: Derivative Liability, Current $588.53K.
| Period end | Derivative Liability, Current |
|---|---|
| 2023-06-30 | $1.96M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $508.64K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $588.53K 10-Q · filed 2023-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |